A Cost Analysis of Non-Invasive Blood-Based microRNA Testing Versus CT Scans for Follow-Up in Patients With Testicular Germ Cell Tumors
Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2019.03.015
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Elsevier BV